Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis

BackgroundsDiabetic cardiomyopathy has a very high incidence and serious clinical consequences, making it an urgent clinical problem to be solved. Angiogenesis is a significant phenotype in the occurrence and development of diabetic cardiomyopathy, especially the damage to angiogenesis of cardiac mi...

Full description

Saved in:
Bibliographic Details
Main Authors: Fengli Hu, Ruixue Guo, Yaxin Zhi, Haijuan Hu, Ting Tang, Pengfei Wang, Ling Xue
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-04-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2025.1561142/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850146707042467840
author Fengli Hu
Fengli Hu
Ruixue Guo
Ruixue Guo
Yaxin Zhi
Yaxin Zhi
Haijuan Hu
Ting Tang
Ting Tang
Pengfei Wang
Pengfei Wang
Ling Xue
author_facet Fengli Hu
Fengli Hu
Ruixue Guo
Ruixue Guo
Yaxin Zhi
Yaxin Zhi
Haijuan Hu
Ting Tang
Ting Tang
Pengfei Wang
Pengfei Wang
Ling Xue
author_sort Fengli Hu
collection DOAJ
description BackgroundsDiabetic cardiomyopathy has a very high incidence and serious clinical consequences, making it an urgent clinical problem to be solved. Angiogenesis is a significant phenotype in the occurrence and development of diabetic cardiomyopathy, especially the damage to angiogenesis of cardiac microvessels, which is inextricably linked to the cardiac risk of diabetic patients. In the current basic and clinical research, there is still a lack of treatment methods that directly target the angiogenesis of diabetic cardiomyopathy. This study hopes to discover the key molecules related to diabetic cardiomyopathy and angiogenesis damage, to provide ideas for possible interventions.MethodsSequencing data of animals and cells were obtained from the GEO database, and differentially expressed genes were analyzed. Subsequently, the angiogenesis-related genes were clustered for functional and pathway analysis. Then, the microangiogenesis of the diabetic mice and the angiogenesis changes of high glucose-stimulated HUVECs were verified, and the top three genes related to diabetic cardiomyopathy and angiogenesis were verified using western blot.Results24 differentially expressed genes associated with angiogenesis were found in GSE241565(human) and GSE215979(mice). Among them, 11 genes showed the same trend in the two databases. Then CD31 staining of diabetic mice hearts showed that microvascular angiogenesis was impaired, high glucose-stimulated HUVECs decreased tube formation, and wound healing migration was weakened. Finally, the top 3 genes most associated with diabetic cardiomyopathy were verified, and there was no significant difference between the changes of Edn1 and Lepr. At the same time, Efnb2 was significantly increased under high glucose stimulation.ConclusionCombined with the sequencing data of animal and cell models of diabetic cardiomyopathy, the differential genes associated with angiogenesis were screened. These findings not only elucidate a novel molecular axis linking angiogenesis damage to diabetic cardiomyopathy but also highlight Efnb2 as a potential therapeutic target.
format Article
id doaj-art-a8b19eff59e641cfbd03bbd91748cae0
institution OA Journals
issn 1664-2392
language English
publishDate 2025-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-a8b19eff59e641cfbd03bbd91748cae02025-08-20T02:27:46ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-04-011610.3389/fendo.2025.15611421561142Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysisFengli Hu0Fengli Hu1Ruixue Guo2Ruixue Guo3Yaxin Zhi4Yaxin Zhi5Haijuan Hu6Ting Tang7Ting Tang8Pengfei Wang9Pengfei Wang10Ling Xue11Department of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, ChinaDepartment of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, ChinaDepartment of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, ChinaDepartment of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, ChinaDepartment of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, ChinaDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, ChinaDepartment of Cardiology, Second Hospital of Hebei Medical University, Shijiazhuang, ChinaBackgroundsDiabetic cardiomyopathy has a very high incidence and serious clinical consequences, making it an urgent clinical problem to be solved. Angiogenesis is a significant phenotype in the occurrence and development of diabetic cardiomyopathy, especially the damage to angiogenesis of cardiac microvessels, which is inextricably linked to the cardiac risk of diabetic patients. In the current basic and clinical research, there is still a lack of treatment methods that directly target the angiogenesis of diabetic cardiomyopathy. This study hopes to discover the key molecules related to diabetic cardiomyopathy and angiogenesis damage, to provide ideas for possible interventions.MethodsSequencing data of animals and cells were obtained from the GEO database, and differentially expressed genes were analyzed. Subsequently, the angiogenesis-related genes were clustered for functional and pathway analysis. Then, the microangiogenesis of the diabetic mice and the angiogenesis changes of high glucose-stimulated HUVECs were verified, and the top three genes related to diabetic cardiomyopathy and angiogenesis were verified using western blot.Results24 differentially expressed genes associated with angiogenesis were found in GSE241565(human) and GSE215979(mice). Among them, 11 genes showed the same trend in the two databases. Then CD31 staining of diabetic mice hearts showed that microvascular angiogenesis was impaired, high glucose-stimulated HUVECs decreased tube formation, and wound healing migration was weakened. Finally, the top 3 genes most associated with diabetic cardiomyopathy were verified, and there was no significant difference between the changes of Edn1 and Lepr. At the same time, Efnb2 was significantly increased under high glucose stimulation.ConclusionCombined with the sequencing data of animal and cell models of diabetic cardiomyopathy, the differential genes associated with angiogenesis were screened. These findings not only elucidate a novel molecular axis linking angiogenesis damage to diabetic cardiomyopathy but also highlight Efnb2 as a potential therapeutic target.https://www.frontiersin.org/articles/10.3389/fendo.2025.1561142/fulldiabeticcardiomyopathyangiogenesisbioinformaticstherapeutictargetsEFNB2
spellingShingle Fengli Hu
Fengli Hu
Ruixue Guo
Ruixue Guo
Yaxin Zhi
Yaxin Zhi
Haijuan Hu
Ting Tang
Ting Tang
Pengfei Wang
Pengfei Wang
Ling Xue
Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis
Frontiers in Endocrinology
diabeticcardiomyopathy
angiogenesis
bioinformatics
therapeutictargets
EFNB2
title Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis
title_full Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis
title_fullStr Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis
title_full_unstemmed Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis
title_short Exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis
title_sort exploring the key target molecules of angiogenesis in diabetic cardiomyopathy based on bioinformatics analysis
topic diabeticcardiomyopathy
angiogenesis
bioinformatics
therapeutictargets
EFNB2
url https://www.frontiersin.org/articles/10.3389/fendo.2025.1561142/full
work_keys_str_mv AT fenglihu exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT fenglihu exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT ruixueguo exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT ruixueguo exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT yaxinzhi exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT yaxinzhi exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT haijuanhu exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT tingtang exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT tingtang exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT pengfeiwang exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT pengfeiwang exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis
AT lingxue exploringthekeytargetmoleculesofangiogenesisindiabeticcardiomyopathybasedonbioinformaticsanalysis